RARA and acute promyelocytic leukemia: The resulting oncoprotein, PML‐RARA, is the key player of APL pathogenesis acting as repressor of transcription of multiple RARA target genes, thus leading to a differentiation block, and uncontrolled proliferation of atypical promyelocytes.1